Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

In the absence of a trial, a matched analysis compared cancer control after salvage focal therapy vs radical prostatectomy (RP) for radiorecurrent prostate cancer.

The FDA has given the green light to beetroot red and has also sanctioned the use of spirulina extract. (HealthDay News) — ...

A trial evaluated the short-term oncologic efficacy of cooled focal therapy ablation using the ProFocal device in men with localized, intermediate-risk prostate cancer.

In patients with AAV, 2 of the novel inflammatory biomarkers evaluated—the Systemic Immune-Inflammatory Index and the Systemic Inflammatory Response Index—recovered after AAV disease-inducing ...

(HealthDay News) — More than four in 10 people older than 50 years (42 percent) have not gotten either a flu or COVID-19 vaccine, according to the results of a survey conducted by the University of ...

Significantly higher sensitivity seen, while specificity was lower for AI-augmented system versus standard of care of analog auscultation.

A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

A study supports targeted conversion of kidney transplant recipients with a history of cutaneous squamous cell carcinoma ...

(HealthDay News) — Patients with neuropathic bladder (NB) undergoing total hip arthroplasty (THA) face significantly higher ...

A phase 3 trial of ferric citrate supports its use as a treatment for iron deficiency anemia in non-dialysis chronic kidney disease (CKD).

Credit: Getty Images Current interventions often fall short in achieving optimal phosphorus levels while imposing substantial burdens on patients. Phosphorus management has long been a cornerstone of ...